This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.
To the Editor.—
As supplementary material to Drs Buswell and Lefkowitz's commentary on "Oral Bronchodilators containing Tartrazine" (235:1111, 1976), readers may find Cohon's article, "Tartrazine Revisited" (Drug Intelligence Clin Pharmacol 9:198, 1975) of use when dealing with tartrazine-sensitive patients. Following a brief review of tartrazine hypersensitivity, Cohon presents a compilation of over 700 tartrazine-containing drugs and drug products from major US pharmaceutical manufacturers. Although formulation changes have undoubtedly occurred since the list's publication, it still remains one of the most comprehensive and attainable lists available. However, as mentioned in The Journal, what's really needed is a full disclosure of such coloring additives on the product labels.
Parker WA. Oral Bronchodilators Containing Tartrazine. JAMA. 1976;236(4):347. doi:10.1001/jama.1976.03270040013017
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: